NUS
Nu Skin Enterprises Inc
NYSE: NUS · CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS
$7.16
+1.99% today
Updated 2026-05-08
Market cap
$360.46M
P/E ratio
2.31
P/S ratio
0.24x
EPS (TTM)
$3.18
Dividend yield
3.40%
52W range
$6 – $14
Volume
0.5M
WallStSmart proprietary scores
73
out of 100
Grade: B
Buy
Investment rating
4.7
Growth
C8.0
Quality
A6.5
Profitability
B9.3
Valuation
A+5/9
Piotroski F-Score
Moderate
4.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →194 stocks currently score above 75
Price targets
Analyst target
$7.50
+4.75%
12-Month target
$12.24
+70.95%
Intrinsic (DCF)
$31.07
Margin of safety
+67.27%
Price chart
Stock snapshot
Strengths
+ Altman Z 4.17 — safe zone
+ ROE 22.00% — strong efficiency
+ 67.27% below intrinsic value
+ Debt/equity 0.45x — low leverage
Risks
- Negative free cash flow $-17.63M
- Revenue declining -16.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.23B | $1.97B | $1.73B | $1.49B | $1.49B |
| Net income | $104.78M | $8.60M | $-146.59M | $160.20M | $1.84M |
| EPS | — | — | — | — | $3.18 |
| Free cash flow | $49.01M | $60.15M | $70.16M | $46.01M | $-17.63M |
| Profit margin | 4.71% | 0.44% | -8.46% | 10.79% | 10.80% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-11 | WOODBURY, EDWINA D | Buy | 14 | $7.31 |
| 2026-03-06 | THOMAS, JAMES D | Buy | 114,706 | — |
| 2026-03-06 | NAPIERSKI, RYAN S | Buy | 282,353 | — |
Peer comparison
Smart narrative
Nu Skin Enterprises Inc trades at $7.16. representing a P/E of 2.31x trailing earnings. Our Smart Value Score of 73/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 4.17, it sits in the safe zone. TTM revenue stands at $1.49B. with profit margins at 10.80%. Our DCF model estimates intrinsic value at $31.07.
Frequently asked questions
What is Nu Skin Enterprises Inc's stock price?
Nu Skin Enterprises Inc (NUS) trades at $7.16.
Is Nu Skin Enterprises Inc overvalued?
Smart Value Score 73/100 (Grade B, Buy). DCF value $31.07.
What is the price target of Nu Skin Enterprises Inc (NUS)?
The analyst target price is $7.50, representing +4.7% upside from the current price of $7.16.
What is the intrinsic value of Nu Skin Enterprises Inc (NUS)?
Based on our DCF model, intrinsic value is $31.07, a +67.3% margin of safety versus $7.16.
What is the future stock price of NUS by 2030?
Our revenue-driven model estimates Nu Skin Enterprises Inc could reach $6.45 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Nu Skin Enterprises Inc's revenue?
TTM revenue is $1.49B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
4.17 — safe zone.
Company info
SectorCONSUMER DEFENSIVE
IndustryHOUSEHOLD & PERSONAL PRODUCTS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.24x
ROE22.00%
Beta1.02
50D MA$7.53
200D MA$9.76
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.5M
Performance
1 week+3.93%
1 month-3.26%
3 months-23.53%
YTD-22.97%
1 year—
3 years—
5 years—